Esther Kong

856 total citations
10 papers, 247 citations indexed

About

Esther Kong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Esther Kong has authored 10 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Esther Kong's work include Gastric Cancer Management and Outcomes (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Glioma Diagnosis and Treatment (2 papers). Esther Kong is often cited by papers focused on Gastric Cancer Management and Outcomes (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Glioma Diagnosis and Treatment (2 papers). Esther Kong collaborates with scholars based in Canada, United States and South Korea. Esther Kong's co-authors include Stephen Yip, Salvatore Di Maio, Robert Rostomily, Sandra E. Dunn, Joanna Triscott, Eric Toyota, Cathy Lee, Mary Rose Pambid, Kaiji Hu and Richard E. Kast and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncotarget.

In The Last Decade

Esther Kong

9 papers receiving 241 citations

Peers

Esther Kong

MB

PRM

CR

GENET

RHEUM

Irene Low New Zealand

Arnau Ulsamer Spain

Ryosuke Tajiri Japan

Jian Xue China

Angela Espósito Italy

Changyoung Yoo South Korea

Masae Kitagawa Japan

Laura Suárez–Fernández Spain

Linda M. Bavisotto United States

Raghu Chandramohan United States

Irene Low New Zealand

Esther Kong

106 ×1.2

MB

77 ×1.2

PRM

32 ×0.6

CR

29 ×0.5

GENET

48 ×1.0

RHEUM

Citations per year, relative to Esther Kong Esther Kong (= 1×) peers Irene Low

Countries citing papers authored by Esther Kong

Since Specialization

Citations

This map shows the geographic impact of Esther Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Kong more than expected).

Fields of papers citing papers by Esther Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Kong. The network helps show where Esther Kong may publish in the future.

Co-authorship network of co-authors of Esther Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Kong. A scholar is included among the top collaborators of Esther Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Kong. Esther Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Gerbec, Zachary J., Antonio Serapio-Palacios, Haggai Bar‐Yoseph, et al.. (2025). Identification of intratumoral bacteria that enhance breast tumor metastasis. mBio. 16(3). e0359524–e0359524. 4 indexed citations

2.

Kong, Esther, et al.. (2023). Abstract 5523: Impact of COVID-19 on longitudinal breast cancer research studies involving TNBC patients. Cancer Research. 83(7_Supplement). 5523–5523.

3.

Maio, Salvatore Di, et al.. (2015). Novel targeted therapies in chordoma: an update. Therapeutics and Clinical Risk Management. 11. 873–873. 44 indexed citations

4.

Li-Chang, Hector, Amy Lum, Esther Kong, et al.. (2015). Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas. BMC Cancer. 15(1). 32–32. 29 indexed citations

5.

Tone, Alicia, Melissa K. McConechy, Winnie Yang, et al.. (2014). Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas. BMC Cancer. 14(1). 982–982. 26 indexed citations

6.

Snuderl, Matija, Joanna Triscott, Paul A. Northcott, et al.. (2014). Deep Sequencing Identifies IDH1 R132S Mutation in Adult Medulloblastoma. Journal of Clinical Oncology. 33(6). e27–e31. 15 indexed citations

7.

Maio, Salvatore Di, et al.. (2013). Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets. Surgical Neurology International. 4(1). 72–72. 14 indexed citations

8.

Kong, Esther, et al.. (2013). Evaluation of hybrid PET/CT gastrography in gastric cancer. Nuklearmedizin - NuclearMedicine. 52(3). 107–112. 3 indexed citations

9.

Jeong, Ji Hoon, et al.. (2013). Evaluation of hybrid PET/CT gastrography in gastric cancer. 4(6). 253–259. 1 indexed citations

10.

Triscott, Joanna, Cathy Lee, Kaiji Hu, et al.. (2012). Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide. Oncotarget. 3(10). 1112–1123. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact